Alix Earle backs Cymbiotika after $150M revenue year
What's the deal? Influencer and investor Alix EarleDealroom has a profile for this one. Try Dealroom → has taken an undisclosed equity stake in San Diego-based liposomal supplement brand Cymbiotika, which reached $150 million in revenue in 2025.
Why now? The investment follows Cymbiotika's expansion into TargetDealroom has a profile for this one. Try Dealroom → and Ulta BeautyDealroom has a profile for this one. Try Dealroom →, as well as its $25 million funding round in November 2025 backed by The WeekndDealroom has a profile for this one. Try Dealroom → and Post MaloneDealroom has a profile for this one. Try Dealroom →.
What it means. Earle joins other celebrity investors in Cymbiotika, including Kendall JennerDealroom has a profile for this one. Try Dealroom →, Hailey BieberDealroom has a profile for this one. Try Dealroom →, Zac EfronDealroom has a profile for this one. Try Dealroom → and Steve AokiDealroom has a profile for this one. Try Dealroom →. The brand is building an omnichannel presence while keeping direct-to-consumer sales at its core.
Read more: MSNBC TV
Image credit: Generated with Gemini
